Details
Stereochemistry | RACEMIC |
Molecular Formula | C15H21NO |
Molecular Weight | 231.3333 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCNC(CC)C(=O)C1=CC2=C(CCC2)C=C1
InChI
InChIKey=VJXZPPKMTRTYIH-UHFFFAOYSA-N
InChI=1S/C15H21NO/c1-3-14(16-4-2)15(17)13-9-8-11-6-5-7-12(11)10-13/h8-10,14,16H,3-7H2,1-2H3
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Indanyl-N-ethylbuphedrone
Created by
admin on Sat Dec 16 10:21:06 GMT 2023 , Edited by admin on Sat Dec 16 10:21:06 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1487882-12-1
Created by
admin on Sat Dec 16 10:21:06 GMT 2023 , Edited by admin on Sat Dec 16 10:21:06 GMT 2023
|
PRIMARY | |||
|
INDANYL-N-ETHYLBUPHEDRONE
Created by
admin on Sat Dec 16 10:21:06 GMT 2023 , Edited by admin on Sat Dec 16 10:21:06 GMT 2023
|
PRIMARY | Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drugmarket | ||
|
112477320
Created by
admin on Sat Dec 16 10:21:06 GMT 2023 , Edited by admin on Sat Dec 16 10:21:06 GMT 2023
|
PRIMARY | |||
|
R7AVR79ZV4
Created by
admin on Sat Dec 16 10:21:06 GMT 2023 , Edited by admin on Sat Dec 16 10:21:06 GMT 2023
|
PRIMARY |
ACTIVE MOIETY